NCT00004809已完成1 期
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
National Center for Research Resources (NCRR)0 个研究点目标入组 5 人开始时间: 1992年6月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
OBJECTIVES:
I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density lipoprotein receptor gene.
详细描述
PROTOCOL OUTLINE: Autologous hepatocytes are obtained from a partial hepatectomy and transduced with a recombinant retroviral vector containing the low-density lipoprotein receptor gene. The transduced hepatocytes are infused via the inferior mesenteric vein 3 days following surgery.
Traditional therapy is discontinued for 4 weeks prior to protocol therapy and may resume 6 weeks after the hepatocyte infusion.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics-- Homozygous familial hypercholesterolemia, i.e.: Low-density lipoprotein (LDL) cholesterol greater than 500 mg/dL Autosomal dominant inheritance Early-onset tendon and tuberous xanthomas LDL receptor negative, i.e.: Receptor binding in cultured fibroblasts no more than 20% of normal OR Genotype with 2 previously described, disease-causing alleles Advanced coronary heart disease with relatively poor prognosis, i.e: Angina pectoris History of myocardial infarction Positive exercise tolerance test Atherosclerotic disease in proximal aorta or coronary arteries by ultrasound or angiogram None of the following: Unstable angina pectoris Left ventricular ejection fraction less than 30% Decompensated congestive heart failure Untreated ventricular tachycardia Moderate to severe aortic stenosis Other dyslipidemia Obstructive hepatobiliary disease
- •Prior/Concurrent Therapy At least 2 weeks since the following: Drugs affecting cholesterol metabolism Plasma exchange LDL apheresis --Patient Characteristics-- Age: Any age Renal: No azotemia No significant proteinuria Other: No hypothyroidism No diabetes
排除标准
- 未提供
研究者
相似试验
Unknown
3 期
Application of PCSK9 Inhibitors in Patients With Heterozygous Familial HypercholesterolemiaPCSK9Efficacy and SafetyHeterozygous Familial HypercholesterolemiaNCT04759534Shenzhen People's Hospital20
已完成
1 期
Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial HypercholesterolemiaHypercholesterolemia, FamilialNCT00515307University of Tehran1
已完成
不适用
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 DiabetesHeart DiseaseType 1 DiabetesNCT01098994University of Pittsburgh87
Unknown
不适用
Genetic Causes of Hypercholesterolaemia in the Emirati PopulationFamilial HypercholesterolemiaNCT03597958Imperial College London Diabetes Centre1,000
已完成
不适用
Screening for Hypercholesterolemia in Children Using Dried Blood SpotHypercholesterolemiaNCT05191355Hospices Civils de Lyon60